Dr. Gironella has specific clinical interest in childhood-onset systemic lupus erythematosus and juvenile idiopathic arthritis, while her academic interests focus on the variability of treatment response to immunosuppressant medications in patients with rheumatic diseases as well as the characterization of patients with very early onset of lupus and other autoimmune diseases. She has served as site investigator in phase 3 clinical trials of a novel therapeutic agent in juvenile idiopathic arthritis. In addition to being board-certified in pediatric rheumatology, Dr. Gironella also has a masters degree in pharmaceutical sciences with specialization in drug development.
View More